Search research articles
Contact Us
Filters
Showing results (121-130 of 129) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 129 results.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2024
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
The New England Journal of Medicine
|
September 30, 2014
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Journal for Immunotherapy of Cancer
|
April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
Jonathan S Cebon, Martin Gore, John F Thompson, et al.
The Lancet. Oncology
|
August 21, 2019
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Robert J Motzer, Brian I Rini, David F McDermott, et al.
Nature Medicine
|
March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Nature Medicine
|
February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Pediatric Blood & Cancer
|
March 27, 2026
Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With Cancer
Edward J Raack, Wan-Chun Chang, Miguel Cordova-Delgado, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases
Mario Mandalà, Monica F Chen, Ryan J Sullivan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 129) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 129 results.
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2024
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
The New England Journal of Medicine
|
September 30, 2014
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Journal for Immunotherapy of Cancer
|
April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
Jonathan S Cebon, Martin Gore, John F Thompson, et al.
The Lancet. Oncology
|
August 21, 2019
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Robert J Motzer, Brian I Rini, David F McDermott, et al.
Nature Medicine
|
March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Nature Medicine
|
February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Pediatric Blood & Cancer
|
March 27, 2026
Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With Cancer
Edward J Raack, Wan-Chun Chang, Miguel Cordova-Delgado, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases
Mario Mandalà, Monica F Chen, Ryan J Sullivan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 13